World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine
Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO
EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax™
EUL...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | COVID-19 | Emergency Medicine | Grants | India Health | International Medicine & Public Health | Pharmaceuticals | SARS | Vaccines | WHO